mHSPC-Therapy with Apalutamide/ADT

Bismarck Ekkehardt; Hammerer Peter; Merseburger Axel S.; Schrader Andres Jan

首页> 外文期刊>Oncology research and treatment. >mHSPC-Therapy with Apalutamide/ADT

【24h】

mHSPC-Therapy with Apalutamide/ADT

机译：MHSPC-Tristapy含Apalutamide / Adt

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2020年第s2期|共7页
作者
Bismarck Ekkehardt; Hammerer Peter; Merseburger Axel S.; Schrader Andres Jan;
展开▼
作者单位

Niedergelassener Urol Urol 24 Nurnberg Germany;

Stadt Klinikum Braunschweig Klin Urol &

Uroonkol Braunschweig Germany;

Univ Klinikum Schleswig Holstein Klin &

Poliklin Urol Lubeck Germany;

Univ Klinikum Munster UKM Klin Urol &

Kinderurol Munster Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-20 18:45:41

相似文献

外文文献
中文文献
专利

1. The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels [J] . Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, BMC Cancer . 2019,第1期

机译：LACOG-0415 II期临床试验：醋酸阿比特龙和ADT与阿帕鲁胺对比乙酸阿比特龙与乙酸阿比特龙与阿帕鲁胺治疗晚期前列腺癌且未cast割睾丸激素水平的患者
2. ERLEADA (R) (Apalutamide) plus ADT approved for mHSPC Therapy [J] . Oncology research and treatment. . 2020,第5期

机译：Erleada（r）（Apalutamide）加上ADT批准用于MHSPC疗法
3. mHSPC therapy with apalutamide/ADT Foreword [J] . von Amsberg Gunhild, Gschwend Juergen Erich Oncology research and treatment. . 2020,第S2期

机译：MHSPC疗法与Apalutamide / Adt前言
4. NATIONAL SURVEY RESULTS - CVI AND ADT COMPLIANCE- VIA STATE ADT COORDINATORS AND STATE VETERINARIANS [C] . Kendra Frasier Annual Meeting of the United^States^Animal^Health^Association. . 2016

机译：国家调查结果 - CVI和ADT合规 - 通过国家ADT协调员和国家兽医
5. ADT cohorts-what keeps them from working: A mixed methods approach. [D] . Jones, Nancy S. 2016

机译：ADT群组-使他们无法工作的原因：混合方法。
6. The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels [O] . Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, 2019

机译：LACOG-0415 II期临床试验：患有非-割睾丸激素水平的晚期前列腺癌患者的醋酸阿比特龙和ADT对比阿帕鲁胺与醋酸阿比特龙对比乙酸阿比特龙和阿帕鲁胺
7. 221P Patient-reported sexual and urinary function in nonmetastatic castration-resistant prostate cancer (nmCRPC) when treated with apalutamide (APA) vs placebo (PBO) and ongoing androgen deprivation therapy (ADT) in SPARTAN [O] . H. Uemura, J.Y. Lee, S. Oudard, 2020

机译：221P患者报告的非偶于抗阉割前列腺癌（NMCRPC）的性和尿液功能在用奥氟脲酰胺（APA）与安慰剂（PBO）和斯巴达持续的雄激素剥夺疗法（ADT）处理时
8. Development of Low-Water Crossing Design Guidelines for Very Low ADT Routes in Illinois. [R] . Bhattarai, R., Kalita, P., Gautam, S., 2016

机译：为伊利诺伊州极低aDT路线制定低水位交叉设计指南。

mHSPC-Therapy with Apalutamide/ADT

著录项

相似文献

相关主题

期刊订阅